Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Jan. 01, 2017	Jan. 03, 2016
Cash flows from operating activities:
Net income	$ 194,029	$ 129,624	$ 161,142
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	125,687	124,304	153,732
Share-based compensation	20,928	18,141	23,231
Impairment of long-lived assets	4,097	16,241	25,001
Deferred income tax	(119,330)	(14,213)	89,026
Non-cash rent (income) expense, net	(11,822)	(7,543)	3,364
Net receipt (recognition) of deferred vendor incentives	1,901	959	(2,559)
System optimization losses (gains), net	39,076	(71,931)	(74,041)
Gain on disposal of the Bakery	0	0	(25,529)
Gain on sale of investments, net	(2,570)	(497)	(335)
Distributions received from TimWen joint venture	11,713	11,426	12,451
Equity in earnings in joint ventures, net	(7,573)	(8,351)	(9,205)
Long-term debt-related activities, net (see below)	12,075	11,767	8,075
Other, net	1,706	4,172	(4,318)
Changes in operating assets and liabilities:
Restricted cash	164	228	(23,640)
Accounts and notes receivable, net	(17,340)	(34,213)	(40,399)
Inventories	(305)	34	(62)
Prepaid expenses and other current assets	(3,488)	(3,276)	(5,409)
Accounts payable	(2,290)	(6,635)	(7,787)
Accrued expenses and other current liabilities	4,982	18,697	(8,424)
Net cash provided by operating activities	251,640	188,934	274,314
Cash flows from investing activities:
Capital expenditures	(81,710)	(150,023)	(251,622)
Acquisitions	(86,788)	(2,209)	(1,232)
Dispositions	81,516	262,173	204,388
Proceeds from sale of the Bakery	0	0	78,408
Changes in restricted cash	24,935	(14,971)	3,634
Notes receivable, net	(9,000)	(3,581)	3,289
Proceeds from sale of investments	4,111	890	621
Payments for investments	375	172	2,106
Net cash (used in) provided by investing activities	(67,311)	92,107	35,380
Cash flows from financing activities:
Proceeds from long-term debt	0	0	2,294,000
Repayments of long-term debt	(28,270)	(24,617)	(1,327,223)
Change in restricted cash	0	0	(5,687)
Deferred financing costs	(1,424)	(1,983)	(43,817)
Repurchases of common stock	(126,231)	(336,958)	(1,098,717)
Dividends	(68,322)	(63,832)	(71,845)
Proceeds from stock option exercises	12,884	19,773	27,952
Payments Related to Tax Withholding for Share-based Compensation	(5,721)	(4,444)	(12,221)
Net cash used in financing activities	(217,084)	(412,061)	(237,558)
Net cash (used in) provided by operations before effect of exchange rate changes on cash	(32,755)	(131,020)	72,136
Effect of exchange rate changes on cash	5,962	2,044	(12,196)
Net (decrease) increase in cash and cash equivalents	(26,793)	(128,976)	59,940
Cash and cash equivalents at beginning of period	198,240	327,216	267,276
Cash and cash equivalents at end of period	171,447	198,240	327,216
Long-term debt-related activities, net:
Accretion of long-term debt	1,237	1,220	1,204
Amortization of deferred financing costs	7,944	7,653	5,426
Loss on early extinguishment of debt	0	0	7,295
Payments for termination of cash flow hedges	0	0	(7,337)
Reclassification of unrealized losses on cash flow hedges	2,894	2,894	1,487
Long-term debt-related activities, net:	12,075	11,767	8,075
Cash paid for:
Interest	128,989	117,583	84,326
Income taxes, net of refunds	29,311	77,620	41,275
Supplemental non-cash investing and financing activities:
Capital expenditures included in accounts payable	5,810	11,325	31,468
Capitalized lease obligations	276,971	104,119	57,226
Accrued debt issuance costs	$ 0	$ 512	$ 0